Related Experiment Video
Updated: Aug 5, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
Abdominal fat thickness predicts the risk of pregnancy-associated hypertension: A prospective cohort study
Xueteng Ding1, Caiping Xiang2, Chao Wei3
1Public Health School, Medical College of Qingdao University, Qingdao, Shandong Province, China.
Insights
Early pregnancy abdominal fat, including subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), predicts pregnancy-associated hypertension (PAH). Nutrient intake did not show a significant association with PAH risk in this study.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Nutritional Science
Background:
- Pregnancy-associated hypertension (PAH) is a common pregnancy complication.
- Maternal obesity is a known risk factor for PAH.
- Nutrition influences obesity and metabolic health, impacting PAH risk.
Purpose of the Study:
- To investigate the association between early-pregnancy abdominal fat thickness (subcutaneous adipose tissue [SAT] and visceral adipose tissue [VAT]) and nutrient intake with the development of PAH.
- To assess the predictive value of adiposity indicators for PAH risk.
Main Methods:
- Prospective cohort study of 1912 pregnant women (9 to 13+6 weeks gestation).
- Abdominal SAT and VAT measured via ultrasound.
- Daily nutrient intake assessed using a validated food frequency questionnaire.
- PAH (gestational hypertension and pre-eclampsia) as the primary outcome.
Main Results:
- Overall PAH incidence was 7.1%.
- High SAT (≥17.05 mm) and high VAT (≥28.85 mm) were independently associated with increased PAH risk (aORs 2.74 and 2.42, respectively), irrespective of BMI.
- Obesity (BMI ≥30 kg/m²) showed a higher aOR (7.04) for PAH compared to overweight (3.16).
- A predictive model using adiposity indicators achieved an AUC of 0.745.
- No significant association found between daily nutrient intake and PAH risk.
Conclusions:
- Early-pregnancy SAT and VAT are significant predictors of PAH, independent of BMI.
- A predictive model incorporating these fat measures aids in early identification of high-risk pregnancies.
- Early identification enables timely interventions to improve perinatal outcomes.
Background And Objectives:
Pregnancy-associated hypertension (PAH) is a prevalent complication during pregnancy. Maternal obesity is a known risk factor for PAH. As nutrition is a key modifiable driver of obesity and metabolic health, this study aimed to evaluate whether early-pregnancy abdominal fat thickness and nutrient intake are associated with the development of PAH.
Methods And Study Design:
A prospective cohort study was conducted including pregnant women during 9 to 13+6 weeks of gestation. The abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured by ultrasound. Daily intake of key nutrients was assessed using a validated food frequency questionnaire. The primary outcome was development of PAH, encompassing gestational hypertension and pre-eclampsia.
Results:
A total of 1912 pregnant women were recruited in this study. The overall incidence of PAH was 7.1% (136/1912). High VAT was associated with a higher PAH incidence than normal VAT (11.2% vs. 4.5%). Independent of BMI, high SAT (≥17.05 mm; adjusted odds ratios (aOR): 2.74, 95% confidence interval (CI): 1.89-3.96) and high VAT (≥28.85 mm; aOR: 2.42, 95% CI: 1.67-3.50) significantly increased risk of PAH. Comparatively, obesity (BMI ≥30 kg/m²) was associated with an aOR of 7.04 (95% CI: 3.94-12.6) for PAH, while the aOR for overweight was 3.16 (95% CI: 2.11-4.71). A predictive model incorporating these adiposity indicators demonstrated an area under the ROC curve of 0.745 (95%CI: 0.703-0.788). In contrast, no significant associations were observed between daily nutrient intake and PAH risk.
Conclusions:
In this prospective cohort study, both early-pregnancy SAT and VAT are significant predictors of PAH independent of BMI. The developed predictive model facilitates the early identification of high-risk women, enabling timely interventions to reduce adverse perinatal outcomes.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Hypodermis
Obesity
Hypertension III: Clinical Manifestations and Diagnostic Studies
